Literature DB >> 35186372

The Dynamic COVID-Zero Strategy in China.

Jue Liu1, Min Liu1, Wannian Liang2,3.   

Abstract

Entities:  

Keywords:  COVID; China; Dynamic; strategy

Year:  2022        PMID: 35186372      PMCID: PMC8837441          DOI: 10.46234/ccdcw2022.015

Source DB:  PubMed          Journal:  China CDC Wkly        ISSN: 2096-7071


× No keyword cloud information.
Since its outbreak in late 2019, coronavirus disease 2019 (COVID-19) has remained a global pandemic for nearly two years, which poses a huge test on the resilience of global public health system (1). After experiencing the large-scale epidemic in February 2020, China has entered a normalization stage of prevention and control since May 2020 (2). In response to the spread of the highly transmissible Delta variant, China adopted a new strategy called “Dynamic COVID-zero” from August 2021. This strategy is a summary of China’s experience in dealing with the spread of the Delta variant, considering how to control the epidemic at a higher level, at a lower cost, and in a shorter time (3). The most important purpose is to minimize the impact of the epidemic on the economy, society, production, and people’s normal lives, and to balance the prevention and control of this disease with socioeconomic stability. For instance, multiple outbreaks that occurred in Beijing were controlled in 2 maximum incubation periods (within 28 days) by this strategy (Figure 1).
Figure 1

Outbreaks of COVID-19 in Beijing from December 2020 to December 2021.

Outbreaks of COVID-19 in Beijing from December 2020 to December 2021. Abbreviation: COVID-19=coronavirus disease 2019. The “Dynamic COVID-zero” strategy is a transitional strategy to be adopted after a successful containment strategy, when the population immunity barrier is not yet established in the face of continued risk of foreign importation and high transmission of variants. This is different from the traditional containment and mitigation strategies (4). The core is to take effective and comprehensive measures to deal with localized COVID-19 cases precisely, to quickly cut off the transmission chain, and to end the epidemic in a timely manner (to “find one, end one”). In other words, China took precise prevention and control measures to quickly find, control, and cure infected people in each cluster outbreak within a specific geographic region to avoid affecting social and economic development in other regions, so as to achieve the maximum effect at the lowest cost. When there is a local recurrence, epidemic prevention staff will quickly find the close contacts using new technologies like big data analysis before the spread in the golden response time (within 24 hours after each outbreak). The aim is to find and control potential infected individuals in advance and try to end the outbreak within one or two maximum incubation periods (Figure 2). The formulation and implementation of this strategy requires extensive community involvement, government funding guarantees, application of new technology, motivating mechanisms, constraint mechanisms, and a resilient health system. Moreover, the scientific suggestions from multidisciplinary experts (for example, public health, clinical medicine, big data analysis, sociology, economics, management, and informatics discipline, etc.) are adopted in a timely manner to support decision making.
Figure 2

The theoretical framework of dynamic COVID-zero strategy.

The theoretical framework of dynamic COVID-zero strategy. With the rapid development of molecular biology technology and the wide use of big data analysis, nucleic acid screening can quickly find the source of infection hidden in the population (5). Strict quarantine and management measures can be subsequently implemented. Big data technology can quickly identify close contacts and risk groups, helping to implement precise prevention and control measures. Compared with severe acute respiratory syndromes (SARS) in 2003, the resilience of China’s health system has been improved, and new technologies such as nucleic acid testing and big data analysis have effectively ensured the implementation of the “Dynamic COVID-zero” strategy. “Dynamic COVID-zero” strategy sums up China’s experience in dealing with Delta, Omicron, and other variants, which has advantages in reducing infection. In general, governments adopt country-specific prevention and control strategies based on their COVID-19 situation, health resources, response capacity and final goals (6). No matter what kind of strategy a country takes, concerted and sustained efforts are needed to end the COVID-19 pandemic globally, especially for curbing the rapid spread of the Omicron variant.

Conflicts of interest

No conflicts of interest.
  6 in total

1.  [Experience and thinking on the normalization stage of prevention and control of COVID-19 in China].

Authors:  W N Liang; J H Yao; J Wu; X Liu; J Liu; L Zhou; C Chen; G F Wang; Z Y Wu; W Z Yang; M Liu
Journal:  Zhonghua Yi Xue Za Zhi       Date:  2021-03-16

Review 2.  Health systems resilience in managing the COVID-19 pandemic: lessons from 28 countries.

Authors:  Victoria Haldane; Chuan De Foo; Salma M Abdalla; Anne-Sophie Jung; Melisa Tan; Shishi Wu; Alvin Chua; Monica Verma; Pami Shrestha; Sudhvir Singh; Tristana Perez; See Mieng Tan; Michael Bartos; Shunsuke Mabuchi; Mathias Bonk; Christine McNab; George K Werner; Raj Panjabi; Anders Nordström; Helena Legido-Quigley
Journal:  Nat Med       Date:  2021-05-17       Impact factor: 53.440

Review 3.  Active case finding with case management: the key to tackling the COVID-19 pandemic.

Authors:  Zhongjie Li; Qiulan Chen; Luzhao Feng; Lance Rodewald; Yinyin Xia; Hailiang Yu; Ruochen Zhang; Zhijie An; Wenwu Yin; Wei Chen; Ying Qin; Zhibin Peng; Ting Zhang; Daxin Ni; Jinzhao Cui; Qing Wang; Xiaokun Yang; Muli Zhang; Xiang Ren; Dan Wu; Xiaojin Sun; Yuanqiu Li; Lei Zhou; Xiaopeng Qi; Tie Song; George F Gao; Zijian Feng
Journal:  Lancet       Date:  2020-06-04       Impact factor: 79.321

4.  Global Percentage of Asymptomatic SARS-CoV-2 Infections Among the Tested Population and Individuals With Confirmed COVID-19 Diagnosis: A Systematic Review and Meta-analysis.

Authors:  Qiuyue Ma; Jue Liu; Qiao Liu; Liangyu Kang; Runqing Liu; Wenzhan Jing; Yu Wu; Min Liu
Journal:  JAMA Netw Open       Date:  2021-12-01

5.  COVID-19 pandemic in BRICS countries and its association with socio-economic and demographic characteristics, health vulnerability, resources, and policy response.

Authors:  Jingmin Zhu; Wenxin Yan; Lin Zhu; Jue Liu
Journal:  Infect Dis Poverty       Date:  2021-07-08       Impact factor: 4.520

  6 in total
  13 in total

1.  Persevere in the Dynamic COVID-Zero Strategy in China to Gain a Precious Time Window for the Future.

Authors:  Jue Liu; Min Liu; Wannian Liang
Journal:  China CDC Wkly       Date:  2022-05-06

2.  The governance of imported 2019-nCov infections: What can be learned from China's experience?

Authors:  Hao Li; Jiaxin He; Jiayu Chen; Shuning Pan; Jiehan Feng; Shuang Liu
Journal:  Glob Health Res Policy       Date:  2022-03-09

3.  Strengthening Community Defenses to Prevent and Control the Spread of COVID-19 in China.

Authors:  Xia Li; Zhuona Zhang; Keyang Lyu; Dongqun Xu
Journal:  China CDC Wkly       Date:  2022-03-11

4.  Reduced incidence of acute pharyngitis and increased incidence of chornic pharyngitis under COVID-19 control strategy in Beijing.

Authors:  Ang Li; Leiliang Zhang
Journal:  J Infect       Date:  2022-04-28       Impact factor: 38.637

5.  How to co-exist with COVID-19? A health economics explanation based on the Chinese experience.

Authors:  Keng Yang; Hanying Qi
Journal:  J Glob Health       Date:  2022-07-16       Impact factor: 7.664

6.  Modeling transmission of SARS-CoV-2 Omicron in China.

Authors:  Jun Cai; Xiaowei Deng; Juan Yang; Kaiyuan Sun; Hengcong Liu; Zhiyuan Chen; Cheng Peng; Xinhua Chen; Qianhui Wu; Junyi Zou; Ruijia Sun; Wen Zheng; Zeyao Zhao; Wanying Lu; Yuxia Liang; Xiaoyu Zhou; Marco Ajelli; Hongjie Yu
Journal:  Nat Med       Date:  2022-05-10       Impact factor: 87.241

7.  Optimizing the dynamic zero-COVID policy in China.

Authors:  Wei Bai; Sha Sha; Teris Cheung; Zhaohui Su; Todd Jackson; Yu-Tao Xiang
Journal:  Int J Biol Sci       Date:  2022-08-21       Impact factor: 10.750

8.  Configurations for positive public behaviors in response to the COVID-19 pandemic: a fuzzy set qualitative comparative analysis.

Authors:  Junwang Gu; Chunmei Wu; Xuanhui Wu; Rong He; Jing Tao; Wenhui Ye; Ping Wu; Ming Hao; Wei Qiu
Journal:  BMC Public Health       Date:  2022-09-06       Impact factor: 4.135

9.  Finding Asymptomatic Spreaders in a COVID-19 Transmission Network by Graph Attention Networks.

Authors:  Zeyi Liu; Yang Ma; Qing Cheng; Zhong Liu
Journal:  Viruses       Date:  2022-07-28       Impact factor: 5.818

10.  The impact of accountability on local officials' behavior in the pandemic prevention and control in China based on utility maximization.

Authors:  Shian Zeng; Chengdong Yi
Journal:  Glob Health Res Policy       Date:  2022-09-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.